Results 151 to 160 of about 13,526 (188)

Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study). [PDF]

Respir Res
Cottin V, Najean M, Arnee E, Voulgaridou M, Dillard C, Ansolabehere X, Doublet M, Chollet J, Leroy S, Jouneau S.   +9 more
europepmc   +1 more source

Nintedanib Lacks Efficacy in a Spirometry-Confirmed and Bleomycin-Induced Mouse Model of Idiopathic Pulmonary Fibrosis. [PDF]

Basic Clin Pharmacol Toxicol
Bousamaki J, Maciag G, Petersen AG, Korntner SH, Jansen SM, Pors SE, Mamsen LS, Rasmussen SA, Salinas CG, Kruse LH, Feigh M, Simonsen U, Hansen HH.   +12 more
europepmc   +1 more source

Posterior reversible encephalopathy syndrome across 22 VEGF-pathway inhibitors in the FDA adverse event reporting system: reporting patterns and reporting-interval characteristics. [PDF]

Front Pharmacol
Li J, Cheng Y, Yang Y.
europepmc   +1 more source

Colorectal cancer cells respond differentially to autophagy induced by tyrosine kinase inhibitors. [PDF]

Sci Rep
Louadj L, Gerotziafas G, Sabbah M, Larsen AK.   +3 more
europepmc   +1 more source

Unilateral lower limb cellulitis-like edema as an atypical cutaneous manifestation of antisynthetase syndrome: a case report and targeted literature review. [PDF]

Front Med (Lausanne)
Zhang Y, Su J, Zhong L, Shang L, Wan H.
europepmc   +1 more source

Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications. [PDF]

Eur Respir Rev
Previtero D, Castelli G, Padrin Y, Scalvenzi F, Ruzzon I, Cocconcelli E, Tinè M, Balestro E, Padoan R, Caminati M, Baraldo S, Spagnolo P, Semenzato U.   +12 more
europepmc   +1 more source

Nintedanib combined with anticoagulant therapy in advanced lung cancer complicated with pulmonary fibrosis and pulmonary embolism: two case reports and clinical decision-making analysis. [PDF]

Front Cardiovasc Med
Zhou X, Zhao L, Ma W, Liu B.
europepmc   +1 more source

Advances in pharmacotherapy for fibrotic interstitial lung disease. [PDF]

Med Rev (2021)
Feng X, Deng M, Miao J, Zheng Z, Hou G.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nintedanib

Reactions Weekly
  +15 more sources